A Multi-Center, Prospective, Randomized Study Comparing Removable, Self-Expanding Metal Stents to Plastic Stents for the Treatment of Benign Biliary Strictures Secondary to Chronic Pancreatitis

Boston Scientific Corporation14 sites in 11 countries172 target enrollmentSeptember 18, 2012

ConditionsBiliary Stricture

Overview

Phase: Not Applicable
Intervention: Not specified
Conditions: Biliary Stricture
Sponsor: Boston Scientific Corporation
Enrollment: 172
Locations: 14
Primary Endpoint: Number of Participants With Stricture Resolution
Status: Completed
Last Updated: 3 years ago

Overview Investigators Eligibility Criteria Outcomes Sites Similar Trials

Overview

Brief Summary

The purpose of this of this study is to compare the use of Self Expanding Metal Stents (SEMS) to plastic stents for the treatment of benign biliary strictures secondary to chronic pancreatitis as it pertains to stricture resolution rates, complication rates and number of endoscopic retrograde cholangiopancreatography (ERCP) procedures during 24 months.

Statistical testing will be performed to determine if the rate of stricture resolution for the metal stent is non-inferior to the plastic stent group.

Registry

clinicaltrials.gov

Start Date

September 18, 2012

End Date

September 21, 2020

Last Updated

3 years ago

Study Type

Interventional

Study Design

Parallel

Sex

All

Investigators

Sponsor

Boston Scientific Corporation

Responsible Party

Sponsor

Eligibility Criteria

Inclusion Criteria

•Age 18 or older
•Willing and able to comply with the study procedures and provide written informed consent to participate in the study
•Chronic pancreatitis
•Symptomatic bile duct stricture (defined by cholangitis or persistent jaundice for at least one month or cholestasis associated with at least 3 times normal alkaline phosphatase levels) documented at time of enrollment for naïve stricture or at the time of prior plastic stent placement in strictures that had one prior plastic stent inserted.12
•Common bile duct stricture based on imaging assessment of dilatation of the common and/or intrahepatic bile ducts

Exclusion Criteria

•Biliary stricture of benign etiology other than chronic pancreatitis
•Prior biliary metal stent or any plastic stenting other than one plastic stent of 10 Fr or less for 6 months or fewer
•Developing obstructive biliary symptoms associated with an attack of acute pancreatitis
•Biliary stricture of malignant etiology
•Stricture within 2 cm of common bile duct bifurcation
•Known bile duct fistula or leak
•Subjects for whom endoscopic techniques are contraindicated
•Known sensitivity to any components of the stent or delivery system
•Symptomatic duodenal stenosis (with gastric stasis)
•Participation in another investigational study within 90 days prior to consent

Outcomes

Primary Outcomes

Number of Participants With Stricture Resolution

Time Frame: After 12-month stenting period through 24 month follow-up (approximately 12 months)

Stricture resolution defined as absence of re-stenting after the 12-month stenting period, and 24 months serum alkaline phosphatase level not exceeding twice the level at the end of stenting period.

Secondary Outcomes

Number of ERCP Procedures Through 24 Months After Initial Stent Placement.(Initial stent placement procedure to 24 month follow-up)
Number of Stents Placed(Initial stent placement procedure to 24 month follow-up)
Serious Adverse Events Related to the Device or Procedure(Initial stent placement procedure to 24 month follow-up)
Ability to Deploy Stent(s) in Satisfactory Position (Technical Success)(Initial stent placement procedure)
Length of Stent Placement and Removal Procedures(Initial stent placement procedure to 24 month follow-up)